Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 12 studies | 25% ± 8% | |
lung | 11 studies | 28% ± 12% | |
kidney | 8 studies | 23% ± 3% | |
intestine | 8 studies | 22% ± 10% | |
liver | 6 studies | 26% ± 17% | |
pancreas | 4 studies | 43% ± 19% | |
bone marrow | 4 studies | 21% ± 2% | |
uterus | 3 studies | 28% ± 14% | |
adrenal gland | 3 studies | 18% ± 3% | |
thymus | 3 studies | 41% ± 19% | |
lymph node | 3 studies | 23% ± 5% | |
breast | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 1155.95 | 180 / 180 | 100% | 110.42 | 430 / 430 |
prostate | 100% | 2566.66 | 245 / 245 | 100% | 358.09 | 502 / 502 |
uterus | 100% | 1235.25 | 170 / 170 | 100% | 197.39 | 459 / 459 |
esophagus | 100% | 1777.96 | 1444 / 1445 | 100% | 110.58 | 183 / 183 |
brain | 100% | 1861.56 | 2640 / 2642 | 100% | 202.13 | 705 / 705 |
breast | 100% | 1538.45 | 459 / 459 | 100% | 175.17 | 1116 / 1118 |
thymus | 100% | 1413.41 | 652 / 653 | 100% | 146.59 | 604 / 605 |
kidney | 100% | 2565.04 | 89 / 89 | 99% | 161.10 | 896 / 901 |
bladder | 100% | 1653.76 | 21 / 21 | 99% | 150.23 | 501 / 504 |
skin | 99% | 1512.18 | 1798 / 1809 | 100% | 165.01 | 471 / 472 |
adrenal gland | 100% | 2441.45 | 258 / 258 | 99% | 120.13 | 228 / 230 |
stomach | 100% | 1520.85 | 359 / 359 | 99% | 128.62 | 283 / 286 |
intestine | 100% | 1896.30 | 966 / 966 | 99% | 137.20 | 520 / 527 |
lung | 98% | 1315.14 | 566 / 578 | 100% | 138.83 | 1153 / 1155 |
liver | 99% | 1009.32 | 223 / 226 | 99% | 111.39 | 400 / 406 |
pancreas | 98% | 879.22 | 320 / 328 | 99% | 128.23 | 177 / 178 |
lymph node | 0% | 0 | 0 / 0 | 100% | 207.26 | 29 / 29 |
muscle | 100% | 3851.17 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1571.78 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 149.93 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 92.49 | 1 / 1 |
adipose | 100% | 1555.49 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1507.97 | 1329 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 154.17 | 79 / 80 |
heart | 98% | 2334.16 | 845 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 82% | 1056.49 | 764 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042797 | Biological process | tRNA transcription by RNA polymerase III |
GO_0042791 | Biological process | 5S class rRNA transcription by RNA polymerase III |
GO_0006383 | Biological process | transcription by RNA polymerase III |
GO_0000127 | Cellular component | transcription factor TFIIIC complex |
GO_0016604 | Cellular component | nuclear body |
GO_0005654 | Cellular component | nucleoplasm |
GO_0003677 | Molecular function | DNA binding |
GO_0000995 | Molecular function | RNA polymerase III general transcription initiation factor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | GTF3C6 |
Protein name | GTF3C6 protein General transcription factor 3C polypeptide 6 (Transcription factor IIIC 35 kDa subunit) (TFIIIC 35 kDa subunit) (TFIIIC35) (Transcription factor IIIC subunit 6) |
Synonyms | NPD020 CDA020 C6orf51 |
Description | FUNCTION: Involved in RNA polymerase III-mediated transcription. Integral, tightly associated component of the DNA-binding TFIIIC2 subcomplex that directly binds tRNA and virus-associated RNA promoters. . |
Accessions | ENST00000329970.8 Q969F1 Q3SWV5 |